Characteristics of Adverse Drug Reactions Due to Nonsteroidal Anti-inflammatory Drugs: a Cross-sectional Study

Overview

Journal Nagoya J Med Sci

Specialty General Medicine

Date 2023 Dec 29

PMID 38155619

Authors

Cholticha Sonsupap

Pattreya Pokhakul

Tetsuyoshi Kariya

Yunosuke Suzuki

Nobuyuki Hamajima

Eiko Yamamoto

Affiliations

Soon will be listed here.

Abstract

Nonsteroidal anti-inflammatory drugs (NSAIDs) are widely used for treating pain and inflammation. Spontaneous adverse drug reaction (ADR) reports represent a rich data source for the detection of unknown and rare ADRs. This cross-sectional study aimed to analyze the characteristics of ADRs due to NSAIDs in Thailand. All ADR reports of NSAIDs for systemic use from 2015 to 2019 were extracted from the national database in Thailand. Patient characteristics, drug use information, adverse event information, and source of senders in 32,857 reports were analyzed. The annual number of ADR reports due to NSAIDs decreased from 7,008 in 2015 to 5,922 in 2019. The most frequently reported drug was ibuprofen (n=12,645, 38.5%) followed by diclofenac (n=7,795, 23.7%), most patients were 40-59 years old, and the major adverse reaction was angioedema (n=7,513, 22.9%). Serious reactions were recorded in 20.7% (n=6,801) of the total ADRs. Most patients (n=20,593, 62.7%) recovered without sequelae, but there were 5,420 patients (16.5%) who could not recover and 3,109 patients (9.5%) who were recovering. Eight patients (0.02%) died of Stevens-Johnson syndrome (n=3), toxic epidermal necrolysis (n=4), and anaphylactic shock (n=1), which were possibly related to ADRs. The number of ADR reports due to NSAIDs decreased from 2015 to 2019 in Thailand. Serious ADRs and death cases accounted for 20.7% and 0.02%, respectively. Most fatal cases exhibited severe drug-induced skin reactions.

Citing Articles

A single epidural administration of butorphanol combined with patient-controlled intravenous analgesia relieves postpartum contraction pain after cesarean section: A randomized clinical trial.

Qiu L, Chen X, Fu J, Hua L, Fan D, Zhang Y Medicine (Baltimore). 2025; 103(52):e40887.

PMID: 39969329 PMC: 11688083. DOI: 10.1097/MD.0000000000040887.

Comparison of the influenza vaccination coverage among high-risk people between the online registration system and walk-in service system in Bangkok, Thailand.

Sairuk R, Nishino K, Inthaphatha S, Hamajima N, Yamamoto E Nagoya J Med Sci. 2024; 86(2):252-261.

PMID: 38962419 PMC: 11219236. DOI: 10.18999/nagjms.86.2.252.

References

Tsumura H, Tamura I, Tanaka H, Chinzei R, Ishida T, Masuda A . Prescription of nonsteroidal anti-inflammatory drugs and co-prescribed drugs for mucosal protection: analysis of the present status based on questionnaires obtained from orthopedists in Japan. Intern Med. 2007; 46(13):927-31. DOI: 10.2169/internalmedicine.46.0003. View

Noda A, Sakai T, Obara T, Miyazaki M, Tsuchiya M, Oyanagi G . Characteristics of pediatric adverse drug reaction reports in the Japanese Adverse Drug Event Report Database. BMC Pharmacol Toxicol. 2020; 21(1):36. PMC: 7245855. DOI: 10.1186/s40360-020-00412-7. View

Zidar N, Odar K, Glavac D, Jerse M, Zupanc T, Stajer D . Cyclooxygenase in normal human tissues--is COX-1 really a constitutive isoform, and COX-2 an inducible isoform?. J Cell Mol Med. 2008; 13(9B):3753-63. PMC: 4516524. DOI: 10.1111/j.1582-4934.2008.00430.x. View

Nissen C, Bindslev-Jensen C, Mortz C . Hypersensitivity to non-steroidal anti-inflammatory drugs (NSAIDs): classification of a Danish patient cohort according to EAACI/ENDA guidelines. Clin Transl Allergy. 2015; 5:10. PMC: 4355575. DOI: 10.1186/s13601-015-0052-0. View

Leenutaphong V, Sivayathorn A, Suthipinittharm P, Sunthonpalin P . Stevens-Johnson syndrome and toxic epidermal necrolysis in Thailand. Int J Dermatol. 1993; 32(6):428-31. DOI: 10.1111/j.1365-4362.1993.tb02814.x. View

Wongrakpanich S, Wongrakpanich A, Melhado K, Rangaswami J . A Comprehensive Review of Non-Steroidal Anti-Inflammatory Drug Use in The Elderly. Aging Dis. 2018; 9(1):143-150. PMC: 5772852. DOI: 10.14336/AD.2017.0306. View

Nguyen D, Vidal C, Chu H, van Nunen S . Human leukocyte antigen-associated severe cutaneous adverse drug reactions: from bedside to bench and beyond. Asia Pac Allergy. 2019; 9(3):e20. PMC: 6676067. DOI: 10.5415/apallergy.2019.9.e20. View

Bacchi S, Palumbo P, Sponta A, Coppolino M . Clinical pharmacology of non-steroidal anti-inflammatory drugs: a review. Antiinflamm Antiallergy Agents Med Chem. 2012; 11(1):52-64. DOI: 10.2174/187152312803476255. View

Gunaydin C, Bilge S . Effects of Nonsteroidal Anti-Inflammatory Drugs at the Molecular Level. Eurasian J Med. 2018; 50(2):116-121. PMC: 6039135. DOI: 10.5152/eurasianjmed.2018.0010. View

10.

Vallano A, Cereza G, Pedros C, Agusti A, Danes I, Aguilera C . Obstacles and solutions for spontaneous reporting of adverse drug reactions in the hospital. Br J Clin Pharmacol. 2005; 60(6):653-8. PMC: 1884880. DOI: 10.1111/j.1365-2125.2005.02504.x. View

11.

Sibbald B . Rofecoxib (Vioxx) voluntarily withdrawn from market. CMAJ. 2004; 171(9):1027-8. PMC: 526313. DOI: 10.1503/cmaj.1041606. View

12.

Lapeyre-Mestre M, Grolleau S, Montastruc J . Adverse drug reactions associated with the use of NSAIDs: a case/noncase analysis of spontaneous reports from the French pharmacovigilance database 2002-2006. Fundam Clin Pharmacol. 2011; 27(2):223-30. DOI: 10.1111/j.1472-8206.2011.00991.x. View

13.

Minghetti L . Cyclooxygenase-2 (COX-2) in inflammatory and degenerative brain diseases. J Neuropathol Exp Neurol. 2004; 63(9):901-10. DOI: 10.1093/jnen/63.9.901. View

14.

Kowalski M, Asero R, Bavbek S, Blanca M, Blanca-Lopez N, Bochenek G . Classification and practical approach to the diagnosis and management of hypersensitivity to nonsteroidal anti-inflammatory drugs. Allergy. 2013; 68(10):1219-32. DOI: 10.1111/all.12260. View

15.

Vonkeman H, van de Laar M . Nonsteroidal anti-inflammatory drugs: adverse effects and their prevention. Semin Arthritis Rheum. 2008; 39(4):294-312. DOI: 10.1016/j.semarthrit.2008.08.001. View

16.

Keohavong B, Vonglokham M, Phoummalaysith B, Louangpradith V, Inthaphatha S, Kariya T . Antibiotic prescription for under-fives with common cold or upper respiratory tract infection in Savannakhet Province, Lao PDR. Trop Med Health. 2019; 47:16. PMC: 6394019. DOI: 10.1186/s41182-019-0143-z. View

17.

Carvajal A, Begaud B, Moride Y, Vega T, Arias L . Under-reporting of adverse drug reactions. Estimate based on a spontaneous reporting scheme and a sentinel system. Eur J Clin Pharmacol. 1998; 54(6):483-8. DOI: 10.1007/s002280050498. View

18.

Durrieu G, Jacquot J, Mege M, Bondon-Guitton E, Rousseau V, Montastruc F . Completeness of Spontaneous Adverse Drug Reaction Reports Sent by General Practitioners to a Regional Pharmacovigilance Centre: A Descriptive Study. Drug Saf. 2016; 39(12):1189-1195. DOI: 10.1007/s40264-016-0463-4. View

19.

Bateman D, Sanders G, Rawlins M . Attitudes to adverse drug reaction reporting in the Northern Region. Br J Clin Pharmacol. 1992; 34(5):421-6. PMC: 1381471. View

20.

Cheng L . Current Pharmacogenetic Perspective on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis. Front Pharmacol. 2021; 12:588063. PMC: 8107822. DOI: 10.3389/fphar.2021.588063. View